Omega Fund IV, L.P. 4
4 · Replimune Group, Inc. · Filed Nov 20, 2019
Insider Transaction Report
Form 4
Omega Fund IV, L.P.
10% Owner
Transactions
- Purchase
Common Stock
2019-11-18$13.61/sh+220,000$2,994,200→ 5,328,939 total
Footnotes (1)
- [F1]The reported securities are held directly by Omega Fund IV, L.P. ("Omega IV"). The reported securities may be deemed to be beneficially owned by each of Omega Fund IV GP, L.P. ("Omega IV GP"), as the general partner of Omega IV, and Omega Fund IV GP Manager, Ltd. ("Omega IV GP Manager"), as the general partner of Omega IV GP. Otello Stampacchia, Anne-Mari Paster and Claudio Nessi (the "Omega Directors") are all the shareholders and directors of Omega IV GP Manager and have shared voting and investment power over the shares held by Omega IV. Each of Omega IV GP, Omega Fund IV GP Manager and the Omega Directors disclaims beneficial ownership of the securities reported herein, except to the extent of its or their pecuniary interest therein, if any. Otello Stampacchia is also a member of the issuer's board of directors.